Works matching DE "KIDNEY disease risk factors"

Results: 1262
    1

    Improving Methodologies for Cumulative Risk Assessment: A Case Study of Noncarcinogenic Health Risks from Volatile Organic Compounds in Fenceline Communities in Southeastern Pennsylvania.

    Published in:
    Environmental Health Perspectives, 2025, v. 133, n. 5, p. 057004-1, doi. 10.1289/EHP14696
    By:
    • Chiger, Andrea A.;
    • Gigot, Carolyn;
    • Robinson, Ellis S.;
    • Tehrani, Mina W.;
    • Claflin, Megan;
    • Fortner, Edward;
    • Stark, Harald;
    • Krechmer, Jordan;
    • Canagaratna, Manjula R.;
    • Herndon, Scott;
    • Yacovitch, Tara I.;
    • Koehler, Kirsten;
    • Rule, Ana M.;
    • Burke, Thomas A.;
    • Fox, Mary A.;
    • DeCarlo, Peter F.;
    • Nachman, Keeve E.
    Publication type:
    Article
    2
    3
    4
    5
    6

    Evaluating Renal Disease in Pediatric‐Onset Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 606, doi. 10.1002/art.43071
    By:
    • Toor, Kirandeep K.;
    • Chen, Audrea;
    • Cabral, David A.;
    • Mammen, Cherry;
    • Bosman, Else S.;
    • Shen, Ye;
    • Bone, Jeffrey N.;
    • Noone, Damien;
    • Al‐Abadi, Eslam;
    • Benseler, Susanne;
    • Berard, Roberta;
    • Bohm, Marek;
    • Charuvanij, Sirirat;
    • Cook, Kathryn;
    • Dancey, Paul;
    • Deepak, Samundeeswari;
    • Duffy, Ciaran;
    • Eberhard, Barbara;
    • Elder, Melissa;
    • Foell, Dirk
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Predictors of Decline in Renal Function 5 Years after EVAR.

    Published in:
    Vascular & Endovascular Surgery, 2022, v. 56, n. 2, p. 166, doi. 10.1177/15385744211054283
    By:
    • Blecha, Matthew;
    • Malach, Lillian;
    • Dickens, Brooke;
    • Decicco, Emily;
    • D'Andrea, Melissa;
    • DeJong, Matthew;
    • Bechara, Carlos F.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Effects of DPP‐4 inhibitors, GLP‐1 receptor agonists, SGLT‐2 inhibitors and sulphonylureas on mortality, cardiovascular and renal outcomes in type 2 diabetes: A network meta‐analyses‐driven approach.

    Published in:
    Diabetic Medicine, 2023, v. 40, n. 8, p. 1, doi. 10.1111/dme.15157
    By:
    • Brønden, Andreas;
    • Christensen, Mikkel Bring;
    • Glintborg, Dorte;
    • Snorgaard, Ole;
    • Kofoed‐Enevoldsen, Allan;
    • Madsen, Gitte Krogh;
    • Toft, Katja;
    • Kristensen, Jette Kolding;
    • Højlund, Kurt;
    • Hansen, Troels Krarup;
    • Søndergaard, Esben;
    • Hansen, Katrine Bagge
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50